HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LONGBIO-B

141.900

+4.4003.20%

Volume:166.85K

Turnover:23.36M

Market Cap:10.53B

PE:-51.92

High:143.300

Open:136.500

Low:136.500

Close:137.500

52wk High:158.000

52wk Low:116.100

Shares:74.19M

HK Float Shares:72.93M

Volume Ratio:0.12

T/O Rate:0.23%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-2.733

ROE:--

ROA:-54.56%

PB:64.69

PE(LYR):-51.92

PS:- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

LongBio Pharma’s LP-003 Hits Primary Goals in China Phase III Seasonal Allergic Rhinitis Study

Bulletin Express

LONGBIO-B's Phase III Trial for Seasonal Allergic Rhinitis Drug LP-003 Meets Primary Endpoint

Longbio Pharma (Suzhou) Co - Phase Iii Trial of Lp-3 for Seasonal Allergic Rhinitis Meets Primary Endpoints

THOMSON REUTERS

LongBio Pharma Announces 2025 AGM; Shareholders to Vote on Profit Distribution, Auditor Re-appointment and Dual Mandates

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/01779"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01779","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01779\",,,,,undefined,":{"symbol":"01779","market":"HK","secType":"STK","nameCN":"LONGBIO-B","latestPrice":141.9,"timestamp":1781165308120,"preClose":137.5,"halted":0,"volume":166850,"delay":0,"changeRate":0.03200000000000004,"floatShares":72930300,"shares":74193200,"eps":-2.733,"marketStatus":"Not Yet Opened","change":4.4,"latestTime":"06-11 16:08:28","open":136.5,"high":143.3,"low":136.5,"amount":23364145,"amplitude":0.049455,"askPrice":142,"askSize":400,"bidPrice":141.8,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-2.62,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1781227800000},"marketStatusCode":0,"adr":0,"listingDate":1780588800000,"exchange":"SEHK","adjPreClose":137.5,"openAndCloseTimeList":[[1781141400000,1781150400000],[1781154000000,1781164800000]],"volumeRatio":0.1179331551791028,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01779\",,,,,undefined,":{"symbol":"01779","floatShares":72930300,"roa":"-54.56%","roe":"--","lyrEps":-2.733,"volumeRatio":0.1179331551791028,"shares":74193200,"dividePrice":0,"high":143.3,"amplitude":0.049455,"preClose":137.5,"low":136.5,"week52Low":116.1,"pbRate":"64.69","week52High":158,"institutionHeld":0,"latestPrice":141.9,"committee":0.111111,"eps":-2.733,"divideRate":0,"volume":166850,"delay":0,"ttmEps":-2.62,"open":136.5,"prevYearClose":96.06,"prevWeekClose":131.8,"prevMonthClose":96.06,"prevQuarterClose":96.06,"fiveDayClose":96.06,"twentyDayClose":96.06,"sixtyDayClose":96.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01779\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01779\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01779\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01779\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01779","date":"2026-06-10","current":-54.160305,"percent":0.5,"low":-51.066007,"twenty":-50.731195,"median":-50.228977,"eighty":-47.272196,"high":-45.301009,"avg":-48.865331,"sd":2.543416,"marketCap":10201558125},"quantilePoints":[{"date":"2026-06-10","current":-50.228977,"twenty":-50.731195,"median":-50.228977,"eighty":-47.272196,"marketCap":10201558125}],"updateTime":1781183911346},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01779\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1118631830","title":"LongBio Pharma’s LP-003 Hits Primary Goals in China Phase III Seasonal Allergic Rhinitis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1118631830","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118631830?lang=en_us&edition=fundamental","pubTime":"2026-06-12 06:20","pubTimestamp":1781216447,"startTime":"0","endTime":"0","summary":"LongBio Pharma (Suzhou) Co., Ltd. reported that its lead candidate LP-003 met all pre-specified primary endpoints in a China-based Phase III clinical trial targeting moderate-to-severe seasonal...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100372939","title":"LONGBIO-B's Phase III Trial for Seasonal Allergic Rhinitis Drug LP-003 Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=1100372939","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100372939?lang=en_us&edition=fundamental","pubTime":"2026-06-12 06:20","pubTimestamp":1781216427,"startTime":"0","endTime":"0","summary":"LONGBIO-B (HKEX: 01779) has announced that the Phase III clinical trial for LP-003, targeting seasonal allergic rhinitis (hay fever), has successfully achieved its pre-defined primary endpoint. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4134","III","01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642237367","title":"Longbio Pharma (Suzhou) Co - Phase Iii Trial of Lp-3 for Seasonal Allergic Rhinitis Meets Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2642237367","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642237367?lang=en_us&edition=fundamental","pubTime":"2026-06-12 06:12","pubTimestamp":1781215949,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nFWN42J0Z4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167380443","title":"LongBio Pharma Announces 2025 AGM; Shareholders to Vote on Profit Distribution, Auditor Re-appointment and Dual Mandates","url":"https://stock-news.laohu8.com/highlight/detail?id=1167380443","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167380443?lang=en_us&edition=fundamental","pubTime":"2026-06-09 22:43","pubTimestamp":1781016201,"startTime":"0","endTime":"0","summary":"LongBio Pharma (Suzhou) Co., Ltd. has issued a notice convening its 2025 Annual General Meeting (AGM) for 4:00 p.m. on 30 June 2026 at the company’s headquarters (5th Floor, Building F, Area A, No....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/01779\",params:#limit:6,delay:false,,,undefined,":[]}}